All terms
Clinical & TrialsClinical Evidence
Pragmatic Trial
A trial designed to evaluate effectiveness in usual-care settings, using broad eligibility, routine workflows, and outcomes meaningful to patients and payers.
Reviewed by Christian Espinosa, Founder, Blue Goat CyberLast reviewed May 9, 2026
Definition
A pragmatic clinical trial is designed to evaluate effectiveness in everyday clinical practice rather than the controlled efficacy demonstrated in tightly designed explanatory trials. Pragmatic trials use broad eligibility, real-world clinical settings, flexible interventions delivered by routine providers, and patient-centered or claims-derived outcomes. The PRECIS-2 framework helps trial designers position a study along the explanatory-pragmatic continuum across nine domains. What the regulation says
FDA's RWE framework increasingly accepts pragmatic-trial evidence to support label expansions and post-market commitments. NIH Pragmatic Trials Collaboratory provides leading methodological work.
What this means in practice
Pragmatic trials are central to value-based care evidence generation and to MedTech post-market studies that support broader reimbursement. Common pitfalls
- •Confusing pragmatic with low-rigor — pragmatic trials still require pre-specified analysis and unbiased outcome ascertainment.
- •Choosing claims data for outcomes without understanding coding lag and accuracy.
Primary references
3 sourcesLink health: 3 verified· last checked 2026-05-09
NIH·1PRECIS-2·1FDA·1
- 1
NIH Pragmatic Trials CollaboratoryVerifiedNIHrethinkingclinicaltrials.org
- 2
PRECIS-2VerifiedPRECIS-2precis-2.org
- 3
FDA - Clinical Trials and Human Subject ProtectionVerifiedFDAfda.gov
Inline markers like [1] jump to the matching reference above.